Skip to main content

Table 5 Effect on experiences following administration of pilocarpine solution to patients with Sjӧgren’s syndrome

From: New low-dose liquid pilocarpine formulation for treating dry mouth in Sjögren’s syndrome: clinical efficacy, symptom relief, and improvement in quality of life

Item VAS (5 cm) a
Pre-administration Continuous administration
Taste 0.6 (0.2, 1.7) 0.9 (0.3, 2.6)
Smell 0.3 (0.1, 0.6) 0.4 (0.2, 1.3)
Irritation 0.4 (0.1, 0.6) 0.4 (0.2, 1.3)
Touch 0.4 (0.1, 1.7) 0.4 (0.2, 1.2)
Ease of use 2.4 (0.7, 3.5) 1.3 (0.8, 3.1)
  1. aVAS, visual analog scale; Median (1st quartile, 3rd quartile), (n = 21)
\